Checking PSA levels following treatment is crucial among patients with nonmetastatic, unfavorable risk prostate cancer, according to the co-author of a recent study.
Improved toxicity, advanced technology, and novel techniques have helped increase the use of radiotherapy for the treatment of different subgroups of patients with prostate cancer.
The evolution of PET scans
Imaging experts compare gallium-based agents to non–gallium-based agents for prostate cancer screening.
A series of new studies examined the impact of prostate cancer on sexual health and quality of life for partners of patients with prostate cancer.
For many men who choose active surveillance, it’s a quality-of-life issue.